As of Oct 09
| +0.0006 / +0.06%|
The 5 analysts offering 12-month price forecasts for Sunesis Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 3.00 and a low estimate of 1.25. The median estimate represents a +116.05% increase from the last price of 0.93.
The current consensus among 7 polled investment analysts is to Hold stock in Sunesis Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.